Cargando…

P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series

POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM: BACKGROUND AND OBJECTIVE: Coronavirus disease-19 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) virus has been associated with increased secondary bacterial and fungal infections. A few center...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Sangeeta, Shastri, Prakash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494446/ http://dx.doi.org/10.1093/mmy/myac072.P174

Ejemplares similares

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

P284 A rare case of post covid bilateral renal mucormycosis
por: Shevkani, Manoj
Publicado: (2022)

P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis
por: Soman, Rajeev, et al.
Publicado: (2022)

P423 Recombinase polymerase amplification for Mucormycosis
por: Hallur, Vinaykumar, et al.
Publicado: (2022)

P277 The epidemiology, clinical manifestations and outcomes of cerebral mucormycosis: A systematic review
por: Salehi, Mohammadreza, et al.
Publicado: (2022)

P163 Successful management of COVID-19-associated mucormycosis in state of pernambuco, northestearn brazil: 2 case reports
por: Batista, Filipe, et al.
Publicado: (2022)

P256 A rare case of co-infection with Nigrospora oryzae with mucormycosis in an immunocompromised post-COVID patient
por: Patel, Ankita, et al.
Publicado: (2022)

P182 Mucormycosis in Northwest Iranian cases with a history of delta COVID-19, a brief report
por: Diba, Kambiz, et al.
Publicado: (2022)

P295 Overview of post-covid mucormycosis in a tertiary care hospital in South India
por: Sridhar, Kripa
Publicado: (2022)

P268 Laryngeal Mucormycosis: does mucor take the voice away?
por: Rege, Sujata, et al.
Publicado: (2022)

P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India
por: Yadav, Sukriti, et al.
Publicado: (2022)

P365 Upsurge of Mucormycosis in COVID-19—a retrospective study in a tertiary care hospital in Punjab
por: Mohan, Sangeetha
Publicado: (2022)

P338 Clinicopathologic analysis of COVID-19-associated mucormycosis-experience from a tertiary care center in north india
por: Sengupta, Arupparna, et al.
Publicado: (2022)

P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital
por: Tak, Kiran, et al.
Publicado: (2022)

P119 Dysregulated IL-23R and CD25 T cells in post -COVID-19 Rhino-Orbital Mucormycosis patients
por: Rai, Gargi, et al.
Publicado: (2022)

P053 Invasive Mucormycosis (Zygomycosis) -Pre-Covid Era and Covid Era: a retrospective study at a tertiary care centre, chennai
por: K, Malavika, et al.
Publicado: (2022)

P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis
por: Perales-Martinez, Diana, et al.
Publicado: (2022)

P407 Standardization of PCR for the diagnosis of invasive aspergillosis and invasive mucormycosis from blood samples
por: Rompally, Satwika, et al.
Publicado: (2022)

P396 Utility of nasal swabs as samples for the diagnosis of Mucormycosis using molecular methods for detection
por: Chowdhury, Souradeep, et al.
Publicado: (2022)

P397 Influence of underlying conditions on disease presentation and diagnostic strategy during pulmonary mucormycosis: Anational study of 114 cases
por: Coste, Anne, et al.
Publicado: (2022)

P282 Bacterial co-infections in Mucormycosis infected COVID-19 patients: experience from a tertiary care center in India
por: Sharad, Neha, et al.
Publicado: (2022)

P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples
por: Choudhary, Hansraj, et al.
Publicado: (2022)

P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series
por: Chakraborty, Sourabh, et al.
Publicado: (2022)

Mucormycosis in renal transplant recipients: review of 174 reported cases
por: Song, Yan, et al.
Publicado: (2017)

S2.1d Incidence of mixed fungal infections in post-COVID-19 outbreak of Mucormycosis
por: Mohapatra, Subhashree, et al.
Publicado: (2022)

P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India
por: Marak, Rungmei S K, et al.
Publicado: (2022)

OA12.04. The role of mind-body awareness in complementary and alternative medicine (CAM) outcomes
por: Sirois, F, et al.
Publicado: (2012)

OA16.01. Patients, physicians, and CAM providers regard communication as central for integrating conventional and CAM therapies for chronic pain
por: Ritenbaugh, C, et al.
Publicado: (2012)

P122 Myeloid-derived suppressor cells as a potential biomarker and therapeutic target in rhino-orbital mucormycosis patients
por: Singh, Praveen, et al.
Publicado: (2022)

P288 Rhinocerebral mucormycosis due to Saksenaea vasiformis in a Sri Lankan patient: A rare fungal infection
por: Sigera, Liyanage Shamithra Madhumali, et al.
Publicado: (2022)

S10.4c Successful treatment of mucormycosis in hematological diseases
por: Kakeya, Hiroshi
Publicado: (2022)

COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
por: Riad, Abanoub, et al.
Publicado: (2021)

P405 Diagnostic performance of MucorGenius® real-time polymerase chain reaction assay on tissue samples for the diagnosis of mucormycosis
por: Pandey, Mragnayani, et al.
Publicado: (2022)

P133 Post-COVID-19 recurrent fungal urinary tract infections: A case series
por: Shetty, Siddhant, et al.
Publicado: (2022)

P259 Rare presentations of Cryptococcosis: a case series
por: Perumalla, Sowjanya, et al.
Publicado: (2022)

P157 Entomophthoromycosis: a rare fungal infection case series
por: Ahmed, Jaweed, et al.
Publicado: (2022)

Zygomaticomaxillary Osteomyelitis due to COVID-19 Associated Mucormycosis (CAM): A Case Series of 10 Patients
por: Datarkar, Abhay N., et al.
Publicado: (2022)

P047 Comparative evaluation of disc diffusion and E-test with broth micro-dilution in susceptibility testing of amphotericin B, posaconazole, isuvuconazole, itraconazole against Rhizopus isolates of post COVID mucormycosis
por: Gupta, Prashant, et al.
Publicado: (2022)

P430 Correlation of microscopy and culture findings with serum ferritin level for the diagnosis of rhino-orbito-cerebral Mucormycosis during COVID-19 pandemic—a study from tertiary care hospital India
por: Lakshmanan, Jothisri, et al.
Publicado: (2022)

OA16.04. Women’s sources of information for CAM use during pregnancy
por: Frawley, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4avpb1hudrgpim1t3500clpk9c